Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1355
| Despition | MERTK Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
| ACPP-1060 | Recombinant Human ADAM17 Protein (Fc Tag) (AC1060) | 50 µg | inquiry |
| ACPP-1488 | Mouse CNTF Protein (AC1488) | 5 µg | inquiry |
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.